It is a pharma private limited company based in Bengaluru, Karnataka, India, established in 2020.
2020 | Bengaluru, Karnataka, India | ActiveDr's Desk Pharmaceutical Private Limited, a active private limited company, was established on 27 August 2020 in Bengaluru, Karnataka, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U51909KA2020PTC137785. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹0.90 M and a paid-up capital of ₹0.10 M.
Employing 10 professional, Its leadership includes Bagali Chethan Gurusiddappa (Director), Lingaraju Raghavendra (Managing Director). Past directors included Pavithra Hatwal Nandaraju, Lingaraju Raghavendra. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Gf002, No 83, Divya Paradise, T G Layout Ittamadu, Banashankari 3Rd Stage, Bengaluru Bangal, Ore, Bengaluru, Karnataka, 560085.
U51909KA2020PTC137785
137785
27 August 2020
₹0.90 M
₹0.10 M
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Dr's Desk Pharmaceutical Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Bagali Chethan Gurusiddappa | Director | 12 Oct 2021 | Current |
| Lingaraju Raghavendra | Managing Director | 27 Aug 2020 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 12 Oct 2021 | Past |
| Pramod Abcsdd | Director | 16 Aug 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Dr'S Desk Pharmaceutical Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 330.76% decrease in profit. The company's net worth observed a substantial decline by a decrease of 281973.2%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Dr'S Desk Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Dr'S Desk Pharmaceutical has a workforce of 10 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Dr'S Desk Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dr'S Desk Pharmaceutical's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Dr'S Desk Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.
Progress on Dr'S Desk Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore. was documented.
Bagali Chethan Gurusiddappa was appointed as a Director was appointed as a Director on 12 Oct 2021 & has been associated with this company since 4 years 2 months . was recorded as a recent event.
Lingaraju Raghavendra was appointed as a Managing Director was appointed as a Managing Director on 27 Aug 2020 & has been associated with this company since 5 years 3 months . was recorded as a recent event.
The activity Dr'S Desk Pharmaceutical Private Limited was registered on 27 Aug 2020 with Roc Bangalore & aged 5 years 3 months as per MCA records. was completed.
The CIN of Dr's Desk Pharmaceutical Private Limited is U51909KA2020PTC137785.
Dr's Desk Pharmaceutical Private Limited is headquartered at Gf002, No 83, Divya Paradise, T G Layout Ittamadu, Banashankari 3Rd Stage, Bengaluru Bangal, Ore, Bengaluru, Karnataka, 560085.
Dr's Desk Pharmaceutical Private Limited was incorporated on 27 August 2020.
The current directors of Dr's Desk Pharmaceutical Private Limited are
The primary industry of Dr's Desk Pharmaceutical Private Limited is Pharma.
Dr's Desk Pharmaceutical Private Limited is unlisted.
The authorized capital of Dr's Desk Pharmaceutical Private Limited is ₹0.90 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX